Stanford University
Showing 151-160 of 626 Results
-
Asiri Ediriwickrema MD, PhD
Assistant Professor of Medicine (Hematology)
BioAsiri Ediriwickrema, MD, PhD, is a physician-scientist who leads a systems hematology laboratory at Stanford and directs a clinical practice focused on myelodysplastic neoplasms and clonal hematopoiesis. Asiri leads a research group that studies hematopoiesis—the complex process by which hematopoietic stem cells generate the diverse blood cells essential for health throughout life. We study how individual blood cells change during aging and cancer development, with particular focus on how dysregulation of this process leads to cytopenias and hematologic malignancies.
Our work integrates expertise spanning clinical medicine, functional hematology, molecular and cellular biology, genomics, bioinformatics, and machine learning. By combining advanced experimental techniques with computational approaches, we examine blood cell development and function at single-cell resolution. We aim to identify early cellular changes in cancer development, map how stem cells interact within their tissue environments, and develop computational tools that predict stem cell behavior and disease progression. Our goal is to translate these efforts into improved diagnostics and precision therapeutic strategies for patients with blood disorders and malignancies.
Dr. Ediriwickrema earned his undergraduate degree in Engineering from the Massachusetts Institute of Technology, his MD (Cum Laude) from Yale University, and his PhD from Stanford University. He completed his residency in Internal Medicine and fellowship in Hematology at Stanford, where he also conducted his doctoral and postdoctoral research in the laboratory of Dr. Ravi Majeti. His research identified novel populations of multipotent progenitor cells in normal hematopoiesis and leukemia stem cells in acute myeloid leukemia (AML). -
Bradley Efron
Max H. Stein Professor and Professor of Statistics and of Biomedical Data Science, Emeritus
Current Research and Scholarly InterestsResearch Interests:
BOOTSTRAP
BIOSTATISTICS
BAYESIAN STATISTICS -
Irmina A. Elliott, MD
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Elliott is a thoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine. She provides the complete spectrum of surgical care for lung cancer, esophageal cancer, mediastinal tumors, and more through the Stanford Health Care Thoracic Cancer Program. She specializes in minimally invasive, including robotic, approaches to thoracic surgery.
Dr. Elliott received fellowship training from Stanford University. She completed her residency at UCLA Medical Center.
Her research has received support from the National Institutes of Health. She has investigated cancer cell response to replication stress, outcomes in patients undergoing hyperthermic intrathoracic chemotherapy (HITHOC) for mesothelioma, complications after esophageal surgery, lymph node involvement in patients with carcinoid tumors of the lung, advanced techniques in robotic surgery, and other topics.
She has authored articles that have appeared in the Proceedings of the National Academy of Sciences (PNAS), Annals of Thoracic Surgery, JAMA Surgery, and other peer-reviewed publications. She also has contributed to textbooks including the content on social disparities in lung cancer for the book Social Disparities in Thoracic Surgery.
Dr. Elliott has made presentations to her peers at meetings of the American Association for Thoracic Surgery, Society of Surgical Oncology, Western Thoracic Surgical Association, and other organizations. Presentations focused on surgical treatment of patients with carcinoid tumor of the lung, improvement of mesothelioma patient survival, complications of esophageal surgery, novel targets for cancer treatment, and more. -
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
On Leave from 07/01/2025 To 06/30/2026Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
